Publication | Open Access

Second-line chemotherapy with pegylated liposomal doxorubicin and carboplatin is highly effective in patients with advanced ovarian cancer in late relapse: a GINECO phase II trial

Pegylated Liposomal DoxorubicinLate RelapseMedicinePharmacologyGynecologyAnti-cancer AgentCancer TreatmentOncologyGynecology OncologyOvarian CancerSecond-line Chemotherapy